NEW YORK, Oct. 9-CuraGen plans to make an announcement regarding cash flow and expenditures early next year, investor relations and corporate communications director Mark Vincent said at the UBS Warburg global life sciences conference here today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: global genetic diversity map, and more.
The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.
In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."
Stat News reports that there's muted opposition to the Kuwaiti DNA database law.